Regencell Bioscience Holdings Stock Performance

RGC Stock  USD 27.23  2.16  8.62%   
Regencell Bioscience holds a performance score of 11 on a scale of zero to a hundred. The company holds a Beta of 2.15, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Regencell Bioscience will likely underperform. Use Regencell Bioscience jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to analyze future returns on Regencell Bioscience.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent technical and fundamental indicators, Regencell Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
8.62
Five Day Return
10.15
Year To Date Return
32.57
Ten Year Return
(54.62)
All Time Return
(54.62)
Last Split Factor
38:1
Last Split Date
2025-06-16
1
This Stock Soared 9,800 percent in 2025. Heres 1 Key Reason Why Investors Are Piling In Stock
11/24/2025
2
Does Regencell Bioscience Face a Deeper Governance Test After Expanded DOJ and Law-Firm Scrutiny
12/22/2025
3
12 Health Care Stocks Moving In Wednesdays Intraday Session
01/07/2026
4
Regencell Bioscience Sees Strong Trading Volume Whats Next
01/08/2026
5
National CineMedia Launches 2026 US Young Lions Competition
01/12/2026
6
Regencell Bioscience Shares Gap Down Whats Next
01/15/2026
7
Oscars Best Picture Nominees and Awards Season Standout Films Return to Regal in March
01/22/2026
8
Movies Theaters Will Sell a Melania Trump Popcorn Bucket This Weekend
01/28/2026
9
A Look At Regencell Bioscience Holdings Valuation After Market Value Surges Despite Ongoing Challenges
01/30/2026
10
Regencell Bioscience Trading Down 10.1 percent - Heres Why - MarketBeat
02/05/2026
Begin Period Cash FlowM
Total Cashflows From Investing Activities2.7 M

Regencell Bioscience Relative Risk vs. Return Landscape

If you would invest  1,383  in Regencell Bioscience Holdings on November 10, 2025 and sell it today you would earn a total of  1,340  from holding Regencell Bioscience Holdings or generate 96.89% return on investment over 90 days. Regencell Bioscience Holdings is generating 1.8825% of daily returns assuming volatility of 13.4032% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Regencell, and most equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Regencell Bioscience is expected to generate 16.5 times more return on investment than the market. However, the company is 16.5 times more volatile than its market benchmark. It trades about 0.14 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Regencell Bioscience Target Price Odds to finish over Current Price

The tendency of Regencell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 27.23 90 days 27.23 
about 27.62
Based on a normal probability distribution, the odds of Regencell Bioscience to move above the current price in 90 days from now is about 27.62 (This Regencell Bioscience Holdings probability density function shows the probability of Regencell Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 2.15 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Regencell Bioscience will likely underperform. Moreover Regencell Bioscience Holdings has an alpha of 1.6211, implying that it can generate a 1.62 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Regencell Bioscience Price Density   
       Price  

Predictive Modules for Regencell Bioscience

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Regencell Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
6.4819.9933.50
Details
Intrinsic
Valuation
LowRealHigh
9.8423.3536.86
Details
Naive
Forecast
LowNextHigh
15.3228.8342.34
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6.0424.3842.72
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regencell Bioscience. Your research has to be compared to or analyzed against Regencell Bioscience's peers to derive any actionable benefits. When done correctly, Regencell Bioscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Regencell Bioscience.

Regencell Bioscience Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Regencell Bioscience is not an exception. The market had few large corrections towards the Regencell Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Regencell Bioscience Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Regencell Bioscience within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.62
β
Beta against Dow Jones2.15
σ
Overall volatility
9.41
Ir
Information ratio 0.13

Regencell Bioscience Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Regencell Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Regencell Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Regencell Bioscience is way too risky over 90 days horizon
Regencell Bioscience appears to be risky and price may revert if volatility continues
Reported Net Loss for the year was (3.58 M) with profit before taxes, overhead, and interest of 0.
Regencell Bioscience Holdings has about 59.41 K in cash with (3.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Regencell Bioscience has a poor financial position based on the latest SEC disclosures
Roughly 89.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Regencell Bioscience Trading Down 10.1 percent - Heres Why - MarketBeat

Regencell Bioscience Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Regencell Stock often depends not only on the future outlook of the current and potential Regencell Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regencell Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding494.5 M
Cash And Short Term Investments4.9 M

Regencell Bioscience Fundamentals Growth

Regencell Stock prices reflect investors' perceptions of the future prospects and financial health of Regencell Bioscience, and Regencell Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Regencell Stock performance.

About Regencell Bioscience Performance

By analyzing Regencell Bioscience's fundamental ratios, stakeholders can gain valuable insights into Regencell Bioscience's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Regencell Bioscience has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Regencell Bioscience has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand(30.84)(32.38)
Return On Tangible Assets(0.56)(0.59)
Return On Capital Employed(0.85)(0.81)
Return On Assets(0.56)(0.59)
Return On Equity(0.85)(0.81)

Things to note about Regencell Bioscience performance evaluation

Checking the ongoing alerts about Regencell Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Regencell Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Regencell Bioscience is way too risky over 90 days horizon
Regencell Bioscience appears to be risky and price may revert if volatility continues
Reported Net Loss for the year was (3.58 M) with profit before taxes, overhead, and interest of 0.
Regencell Bioscience Holdings has about 59.41 K in cash with (3.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Regencell Bioscience has a poor financial position based on the latest SEC disclosures
Roughly 89.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Regencell Bioscience Trading Down 10.1 percent - Heres Why - MarketBeat
Evaluating Regencell Bioscience's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Regencell Bioscience's stock performance include:
  • Analyzing Regencell Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Regencell Bioscience's stock is overvalued or undervalued compared to its peers.
  • Examining Regencell Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Regencell Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Regencell Bioscience's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Regencell Bioscience's stock. These opinions can provide insight into Regencell Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Regencell Bioscience's stock performance is not an exact science, and many factors can impact Regencell Bioscience's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Regencell Stock analysis

When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account